This Solicitation opportunity from Department Of Defense was posted on August 31, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

SCOPOLAMINE TRANSDERMA

Closed

SPE2DP-26-T-4809Federal

Submission Closed09/08/2026, 05:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325411

New

DIBBS

Supply of Pressure Sensitive Adhesive Plastic StripsThis subcontract opportunity is for the manufacture and supply of gray pressure-sensitive adhesive plastic strips to support prime contractors delivering DLA Troop Support Construction and Equipment supply contracts. The required strips must be 6 inches wide and 0.014 inches thick, featuring liners score-slit at 1-inch intervals parallel to the length. The final delivery consists of 16 rolls, each 36 yards in length and matching color specification 36320. Managed by the Department of Defense through Depot Oklahoma, the performance location for this contract is Tinker AFB. This is a Total Small Business Set-Aside under NAICS code 325411. Interested parties must maintain an active SAM registration to be eligible. The response deadline for this solicitation is November 9, 2026.

POSTED

DEADLINE

Solicitation # SPE2DP-27-T-0198

Solicitation SPE2DP-27-T-0198 is a request for quotations issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of Salicylic Acid Gel. The required material, identified by NSN 6505017252933, is a maximum strength, fast acting gel containing 17% Salicylic Acid, supplied in 7 gram (0.25oz) tubes. The contract specifies a quantity of one unit to be delivered FOB Destination to Fort George G Meade, Maryland, with a required delivery timeline of five days after receipt of order and an original required delivery date of October 22, 2026. The procurement is subject to strict quality and packaging standards, including storage at medical controlled room temperature and marking in accordance with Medical Marking Standard No. 1, which supersedes MIL-STD-129. Packaging must follow MIL-STD-2073-1E and RP001 for palletization, with each unit secured in a sealed container to prevent damage. Administrative requirements include electronic invoicing via the Wide Area WorkFlow system and compliance with various FAR and DFARS clauses regarding cybersecurity, domestic origin of materials, and the prohibition of additive manufacturing. Quotations are due by November 3, 2026, and are encouraged to be submitted via DIBBS.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

MULTIVITAMIN SOLUTION

Solicitation # SPE2DP-27-T-0196

Solicitation SPE2DP-27-T-0196 is a request for quotations issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of two units of Pediatric Multivitamin No. 192 oral drops (50ML), identified by NSN 6505016962244. The product must be stored at medical controlled room temperature and has a non-extendable shelf life of 15 months. Delivery is required within five days after receipt of order, with a required delivery date of October 29, 2026. The shipment is destined for the USS Princeton (CG 59) and is designated as a vessel shipment. The contract mandates strict adherence to Medical Marking Standard No. 1, which supersedes MIL-STD-129. Packaging must be commercial, utilizing suitable sealed unit containers and exterior shipping containers in accordance with MIL-STD-2073-1E and DLA packaging requirements (RP001). Inspection and acceptance will occur at the destination per FAR 52.246-2. Administrative requirements include electronic invoicing through the Wide Area WorkFlow system and compliance with various FAR and DFARS clauses, including the Buy American Act and cybersecurity reporting standards. Quotations are due by November 3, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

CALCIUM CARBONATE TABL

Solicitation # SPE2DP-27-T-0199

Solicitation SPE2DP-27-T-0199 is a small business set-aside issued by the Defense Logistics Agency for the procurement of 10 bottles of regular strength, peppermint flavored calcium carbonate chewable tablets. Each bottle must contain 150 tablets of 500 mg each, intended for the relief of heartburn, acid indigestion, and upset stomach. The items are subject to a non-extendable shelf life of 36 months and must be stored at room temperature in tightly closed containers. Delivery is required within 5 days after order, with an original required delivery date of October 30, 2026, to a destination at Fort Stewart, Georgia. The contract mandates strict adherence to DLA packaging and marking standards, specifically MIL-STD-2073-1E and Medical Marking Standard No. 1, with palletization following RP001 requirements. Inspection and acceptance will occur at the destination. Administrative requirements include the use of the Wide Area WorkFlow system for invoicing and compliance with various FAR and DFARS clauses, including NIST SP 800-171 for cybersecurity and the Buy American Act for domestic material preferences. Quotations for this requirement must be submitted to the DLA Troop Support office in Philadelphia by November 3, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Oral Rehydration Salts (ORS)This subcontract, managed by the Medical Supply Chain Pharm FSA under the Department of Defense, involves the supply of orange-flavored electrolyte oral hydration powder for prime contractors on DLA supply contracts. The requirement is for 2,000 packages of rehydration salts, with each package containing 100 units of 21 GM oral solution packets, strictly adhering to NSN 6505016871441 specifications. The contractor must ensure full compliance with all DLA Technical/Quality Requirements and DLAD regulations. The performance of this contract is designated for FPO 96679, with a response deadline set for November 2, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

NORGESTIMATE AND ETHIN

Solicitation # SPE2DP-27-T-0174

Solicitation SPE2DP-27-T-0174 is a fixed-price request for quotations issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of one package of norgestimate and ethinyl estradiol tablets, consisting of 6 cycles and 168 tablets. The item is regulated by the FDA and must be delivered to the 0189 CS BN CO A Composite AWCF SSA at Fort Bragg, North Carolina, within 20 days after the order is placed. The original required delivery date is October 27, 2026. The product must be stored at 25 degrees Celsius, protected from light, and carries a non-extendable shelf life of 36 months. The contract mandates strict adherence to packaging and marking standards, including MIL-STD-129, Medical Marking Standard No. 1, and RP001 for palletization. If the material is deemed hazardous per FED-STD-313, it must follow TQ requirement IP025 and the Hazard Communication Standard; otherwise, it should be commercially packaged per ASTM D3951. Inspection and acceptance will occur at the destination. Administrative requirements include the use of the Wide Area WorkFlow system for invoicing and compliance with the Buy American Act and NIST SP 800-171 assessment requirements. This is not a small business set-aside, and all quotes must be submitted via the DLA Internet Bid Board System.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

PLASMA-LYTE A INJECTIO

Solicitation # SPE2DP-27-T-0176

Solicitation SPE2DP-27-T-0176 is a fixed-price procurement issued by the DLA Troop Support Medical Supply Chain Pharm FSA for 20 units of Plasma-Lyte A Injection. The product is a pH 7.4 multiple electrolytes injection provided in 500 mL VIAFLEX plastic containers and must be stored at room temperature. The required delivery date is October 27, 2026, with delivery to the 0189 CS BN CO A Composite AWCF SSA at Fort Bragg, North Carolina. Shipping must be executed via the fastest traceable means, and the use of parcel post is explicitly prohibited. The contract mandates strict adherence to Medical Marking Standard No. 1, which supersedes MIL-STD-129. Packaging must be commercial, utilizing sealed unit containers and exterior shipping containers that protect the contents from damage, with palletization following RP001 DLA requirements. The item is classified as a Type I (Code J) item with a non-extendable shelf life of 15 months. Inspection and acceptance will occur at the destination. Administrative requirements include the use of the Wide Area WorkFlow (WAWF) system for invoicing and compliance with the Buy American Act and Berry Amendment. This is not a small business set-aside, and the applicable NAICS code is 325411.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

REHYDRATION SALTS FOR

Solicitation # SPE2DP-27-T-0170

Solicitation SPE2DP-27-T-0170 is issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of orange flavored electrolyte oral hydration powder. The requirement consists of two packages of rehydration salts, specifically 21 gram units in packages of 100, under NSN 6505016871441. The items must have a non-extendable shelf life of 36 months. Delivery is required within 20 days after receipt of order, with a final required delivery date of October 23, 2026. The shipment is destined for the USS TUCSON SSN 770, with FOB and inspection/acceptance points set at the destination. Compliance with strict packaging and marking standards is mandatory. All materials must be marked according to Medical Marking Standard No. 1, which supersedes MIL-STD-129. Non-hazardous materials must follow ASTM D3951, while hazardous materials require packaging per TQ requirement IP025 and the submission of a Safety Data Sheet. Palletization must adhere to DLA packaging requirement RP001. The contract incorporates various federal regulations, including the Buy American and Balance of Payments Program and the safeguarding of covered defense information. Invoicing and payment processing are to be handled electronically through the Wide Area WorkFlow system.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

AZELASTINE HYDROCHLORI

Solicitation # SPE2DP-27-T-0160

Solicitation SPE2DP-27-T-0160 is a request for quotations issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of Azelastine Hydrochloride Nasal Solution 0.1% nasal spray, with 137 micrograms per spray. The requirement consists of 30 bottles under CLIN 0001, with an original required delivery date of October 27, 2026. The product must be stored upright between 20 C to 25 C and protected from freezing. Delivery is set as FOB Destination, with both inspection and acceptance occurring at the destination in Vilseck, Germany. The contract mandates strict adherence to quality and packaging standards, including the DLA Master List of Technical and Quality Requirements (RA001), MIL-STD-2073-1E for packaging, and Medical Marking Standard No. 1 for labeling. Palletization must comply with RP001. Administratively, the solicitation is not a small business set-aside and falls under NAICS code 325411. It incorporates various FAR and DFARS clauses, including the Buy American Act, safeguarding of covered defense information, and the use of the Wide Area WorkFlow system for electronic invoicing. All quotes must be submitted via the DLA Internet Bid Board System.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

BENZOCAINE AND MENTHOL

Solicitation # SPE2DP-27-T-0155

Solicitation SPE2DP-27-T-0155 is a fixed-price contract issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of Cepacol Extra Strength Sore Throat Honey Lemon Lozenges. The product, identified by NSN 6505017081449, contains 15mg of Benzocaine and 2.6mg of Menthol and is supplied in packages of 16. The requirement is split across multiple CLINs with total quantities including 14, 10, and 3 units, with a required delivery date of October 27, 2026. Deliveries are FOB Destination, with shipping locations specified in Vilseck, Germany, and Fort Campbell, Kentucky. The contract mandates strict medical quality and storage standards, requiring items to be stored between 20-25 C and protected from humidity. Packaging must be commercial and utilize sealed unit containers to prevent damage, with palletization adhering to RP001 DLA requirements. All materials must be marked according to Medical Marking Standard No. 1, which supersedes MIL-STD-129. Administrative requirements include electronic invoicing via the Wide Area WorkFlow system and compliance with various FAR and DFARS clauses regarding cybersecurity, hazardous material labeling, and the prohibition of additive manufacturing unless authorized.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

ANALGESIC GEL, TOPICAL

Solicitation # SPE2DP-27-T-0166

Solicitation SPE2DP-27-T-0166, issued by the DLA Troop Support Medical Supply Chain Pharm FSA, is a request for quotations for the procurement of 36 tubes of Biofreeze topical analgesic gel. The product is a colorless gel containing 5% Menthol USP in 4 oz (118ml) tubes, intended for adults and children aged two years and older. Key technical requirements include a non-extendable shelf life of 24 months and specific storage conditions between 20-25 C (68-77 F) in a cool, dry place away from direct sunlight. Due to its flammable nature, the product must be kept away from excessive heat or open flames. The contract specifies delivery FOB Destination to the USALRCTR Bavaria in Vilseck, Germany, with a required delivery date of October 27, 2026, and a delivery window of five days after receipt of order. Packaging must be commercial and compliant with MIL-STD-2073-1E and RP001, while marking must adhere to Medical Marking Standard No. 1. Inspection and acceptance will occur at the destination per FAR 52.246-2. Administrative requirements include the use of the Wide Area WorkFlow (WAWF) system for electronic invoicing and payment. This is not a small business set-aside, though a HUBZone price evaluation preference may be applied.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

NOI - B2B Award entitled - Developing Red Cell-Sp

Solicitation # 75N98027Q00017

Solicitation 75N98027Q00017 is a combined synopsis and notice of intent for a non-competitive award by the National Institutes of Health (NIH) to Purdue University, specifically the Purdue Institute for Drug Discovery. The contract supports the Bench-to-Bedside study Developing Red Cell-Specific Spleen Tyrosine Kinase (SYK) Inhibitors for Treating Sickle Cell Disease. The scope of work for the Year 1 requirement involves the synthesis, scale-up, characterization, and optimization of lead SYK inhibitors S1115 and S1213, with a delivery requirement of approximately 3 to 5 grams of each compound along with supporting analytical and potency data. The award is justified as non-competitive because Purdue University possesses the project-specific knowledge and prior research experience necessary to avoid technical risk and duplication of effort. The acquisition is conducted under FAR 12.603 for commercial items and is not expected to exceed the simplified acquisition threshold. Research activities will be performed at Purdue University in West Lafayette, Indiana, with deliverables sent to the National Heart, Lung, and Blood Institute in Bethesda, Maryland. The associated NAICS code is 325411 for Medicinal and Botanical Manufacturing, and the requirement is not set aside for small businesses. Administrative requirements include active registration in the System for Award Management and the use of the Invoicing Processing Platform for three-way match payments. Responses were due by November 4, 2026, to the contracting specialist, Nicholas Capobianco.

National Institutes Of Health Olao

POSTED

9 days ago

DEADLINE

in 6 days

AI Contract Overview

Solicitation SPE2DP-26-T-4809 is a fixed-price request for quotations issued by the DLA Troop Support Medical Supply Chain for the acquisition of Scopolamine Transdermal Systems (NSN 6505-01-692-5042). The requirement consists of three line items, each for one box of 1.5mg patches released over a three-day period. This is a small business set-aside procurement with a delivery lead time of five days after order. The materials are to be delivered FOB Destination to the medical logistics facility at Fort Bragg, North Carolina, using the fastest traceable means, specifically excluding parcel post. The contract mandates strict adherence to Medical Marking Standard No. 1, which supersedes MIL-STD-129. Packaging must be commercial, utilizing suitable sealed unit containers and exterior shipping containers to prevent damage, with palletization following DLA requirement RP001. The product must be stored at a controlled room temperature between 68 F and 77 F. Inspection and acceptance will occur at the destination. Offerors must submit quotes via the DIBBS portal and are encouraged to provide quantity ranges due to demand volatility. Compliance with the Buy American Act, Berry Amendment, and various FAR/DFARS clauses regarding cybersecurity and trafficking in persons is required.

General Info

Baxter Healthcare supplies Scopolamine patches to Fort Bragg via fast, traceable shipping.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

NAICS

325411 - Medicinal and Botanical Manufacturing

Place of Performance

BLD A5474 PRATT ST, FORT BRAGG, NC, 28310, USA

Set-Aside

NONE

Documents

SPE2DP-26-T-4809 RFQ for quotations

rfq

High

AI Contract Breakdown

Uniform Contract Format

Timeline

2 updates

PhaseClosed

PostedAug 31

Solicitation

Notice updatedAug 31

The notice description changed.

Notice updatedAug 31

The notice description changed.

Response DeadlineSep 8

Deadline has passed

Submission Closed

09/08/2026, 05:00:00 PM UTC

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Contacts1 person available

OfficeUSA

Organization / AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Office AddressUSA

Contacts

Lawrence Garnett

contact@example.gov

+1 (555) 000-0000

Full Description

SCOPOLAMINE TRANSDERMAL SYSTEM
SCOPOLAMINE TRANSDERMAL SYSTEM
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS
SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED
IN A SUITABLE SEALED UNIT CONTAINER CAPABLE
OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR
BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL
EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN
NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND
SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT
THE LOWEST RATE, TO POINT OF DELIVERY CALLED
FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING
STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES
TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1
(MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA
TROOP SUPPORT VIA EMAIL TO contact@example.gov. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
TRANSDERM-SCOPOLAMINE 1.5MG (1MG/3D) 10 EACH PER BOX.
U/I (1) BOX
SCOPOLAMINE TRANSDERMAL SYSTEM 1.5MG RELEASED OVER A 3 DAY PERIOD: Store at controlled room temperature between 68 F to 77 F (20 C to 25 C). Store pouch(es) in an upright position. Do not bend or roll pouch(es).
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
RS020: Shelf-life requirement RS001 for a TYPE I (CODE Q) item with a shelf life of 36 months (non-extendable) applies to this item.
SPE2DP-26-T-4809
SECTION B
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
SHALL BE MARKED IAW THE LATEST EDITION OF
THE MEDICAL MARKING STANDARD NO. 1.
MMS NO. 1 IS AVAILABLE ONLINE AT:
https://www.dla.mil/Logistics-Operations/Packaging/
BAXTER HEALTHCARE CORPORATION 1G026 P/N NDC10019-0553-03
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7018111697 0001 BX 1.000
NSN/MATERIAL:6505016925042
DELIVERY (IN DAYS):0005
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
QUP:001 PRES MTHD:ZZ CLNG/DRY:Z PRESV MAT:ZZ
WRAP MAT:ZZ CUSH/DUNN MAT:ZZ CUSH/DUNN THKNESS:Z
UNIT CONT:ZZ OPI:M
INTRMDTE CONT:ZZ INTRMDTE CONT QTY:ZZZ
PACK CODE:U
MARKING SHALL BE IN ACCORDANCE WITH MIL-STD-129.
SPECIAL MARKING CODE:ZZ -ZZ Special Requirements
PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED IN A SUITABLE SEALED UNIT CONTAINER CAPABLE OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT THE LOWEST RATE, TO POINT OF DELIVERY CALLED FOR IN THE CONTRACT OR ORDER.
SPE2DP-26-T-4809
SECTION B
PR: 7018111697 PRLI: 0001 CONT’D
MATERIAL MUST BE MARKED IAW MEDICAL MARKING
STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES
TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1
(MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA
TROOP SUPPORT VIA EMAIL TO contact@example.gov. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
BULK BREAK POINT:
W50YF2
0051 MD CO MEDICAL LOGISTI
AWCF SSF
BLD A5474 PRATT ST
FORT BRAGG NC 28310
US
SHIP BY FASTEST TRACEABLE MEANS. DO NOT USE PARCEL POST.
FREIGHT SHIPPING ADDRESS:
W50YF2
0051 MD CO MEDICAL LOGISTI
AWCF SSF
BLD A5474 PRATT ST
FORT BRAGG NC 28310
US
MARKFOR
W50YF2
0051 MD CO MEDICAL LOGISTI
AWCF SSF
BLD A5474 PRATT ST
FORT BRAGG NC 28310
US
M/F: (TCN) W50YF262400081
RDD: 254
PROJ: TP 1
SUPP ADD: W9046W SIG: C
FOR GOVERNMENT USE ONLY: (IPD) 02
DIC: A0A DIST: V ADV: 2A FC: Z9
Need Ship Date:00/00/0000 Original Required Delivery Date:09/02/2026
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
SPE2DP-26-T-4809
SECTION B
PR: 7018128539 PRLI: 0001 CONT’D
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0002 7018128539 0001 BX 1.000
NSN/MATERIAL:6505016925042
DELIVERY (IN DAYS):0005
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
QUP:001 PRES MTHD:ZZ CLNG/DRY:Z PRESV MAT:ZZ
WRAP MAT:ZZ CUSH/DUNN MAT:ZZ CUSH/DUNN THKNESS:Z
UNIT CONT:ZZ OPI:M
INTRMDTE CONT:ZZ INTRMDTE CONT QTY:ZZZ
PACK CODE:U
MARKING SHALL BE IN ACCORDANCE WITH MIL-STD-129.
SPECIAL MARKING CODE:ZZ -ZZ Special Requirements
PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED IN A SUITABLE SEALED UNIT CONTAINER CAPABLE OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT THE LOWEST RATE, TO POINT OF DELIVERY CALLED FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1 (MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA TROOP SUPPORT VIA EMAIL TO contact@example.gov. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
PKGING DATA MIL-STD-2073-1E
QUP:001 PRES MTHD:ZZ CLNG/DRY:Z PRESV MAT:ZZ
WRAP MAT:ZZ CUSH/DUNN MAT:ZZ CUSH/DUNN THKNESS:Z
UNIT CONT:ZZ OPI:M
INTRMDTE CONT:ZZ INTRMDTE CONT QTY:ZZZ
PACK CODE:U
MARKING SHALL BE IN ACCORDANCE WITH MIL-STD-129.
SPE2DP-26-T-4809
SECTION B
PR: 7018128539 PRLI: 0001 CONT’D
SPECIAL MARKING CODE:ZZ -ZZ Special Requirements
PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED IN A SUITABLE SEALED UNIT CONTAINER CAPABLE OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT THE LOWEST RATE, TO POINT OF DELIVERY CALLED FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1 (MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA TROOP SUPPORT VIA EMAIL TO contact@example.gov. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
BULK BREAK POINT:
W50YF2
0051 MD CO MEDICAL LOGISTI
AWCF SSF
BLD A5474 PRATT ST
FORT BRAGG NC 28310
US
SHIP BY FASTEST TRACEABLE MEANS. DO NOT USE PARCEL POST.
FREIGHT SHIPPING ADDRESS:
W50YF2
0051 MD CO MEDICAL LOGISTI
AWCF SSF
BLD A5474 PRATT ST
FORT BRAGG NC 28310
US
MARKFOR
W50YF2
0051 MD CO MEDICAL LOGISTI
AWCF SSF
BLD A5474 PRATT ST
FORT BRAGG NC 28310
US
SPE2DP-26-T-4809
SECTION B
PR: 7018128539 PRLI: 0001 CONT’D
M/F: (TCN) W50YF262380048
RDD: 252
PROJ: TP 1
SUPP ADD: W9046W SIG: C
FOR GOVERNMENT USE ONLY: (IPD) 02
DIC: A0A DIST: V ADV: 2A FC: Z9
Need Ship Date:00/00/0000 Original Required Delivery Date:09/03/2026
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0003 7018106186 0001 BX 1.000
NSN/MATERIAL:6505016925042
DELIVERY (IN DAYS):0005
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
QUP:001 PRES MTHD:ZZ CLNG/DRY:Z PRESV MAT:ZZ
WRAP MAT:ZZ CUSH/DUNN MAT:ZZ CUSH/DUNN THKNESS:Z
UNIT CONT:ZZ OPI:M
INTRMDTE CONT:ZZ INTRMDTE CONT QTY:ZZZ
PACK CODE:U
MARKING SHALL BE IN ACCORDANCE WITH MIL-STD-129.
SPECIAL MARKING CODE:ZZ -ZZ Special Requirements
PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED IN A SUITABLE SEALED UNIT CONTAINER CAPABLE OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT
SPE2DP-26-T-4809
SECTION B
PR: 7018106186 PRLI: 0001 CONT’D
THE LOWEST RATE, TO POINT OF DELIVERY CALLED
FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING
STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES
TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1
(MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA
TROOP SUPPORT VIA EMAIL TO contact@example.gov. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
PKGING DATA MIL-STD-2073-1E
QUP:001 PRES MTHD:ZZ CLNG/DRY:Z PRESV MAT:ZZ
WRAP MAT:ZZ CUSH/DUNN MAT:ZZ CUSH/DUNN THKNESS:Z
UNIT CONT:ZZ OPI:M
INTRMDTE CONT:ZZ INTRMDTE CONT QTY:ZZZ
PACK CODE:U
MARKING SHALL BE IN ACCORDANCE WITH MIL-STD-129.
SPECIAL MARKING CODE:ZZ -ZZ Special Requirements
PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED IN A SUITABLE SEALED UNIT CONTAINER CAPABLE OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT THE LOWEST RATE, TO POINT OF DELIVERY CALLED FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1 (MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA TROOP SUPPORT VIA EMAIL TO contact@example.gov. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
PKGING DATA MIL-STD-2073-1E
QUP:001 PRES MTHD:ZZ CLNG/DRY:Z PRESV MAT:ZZ
WRAP MAT:ZZ CUSH/DUNN MAT:ZZ CUSH/DUNN THKNESS:Z
UNIT CONT:ZZ OPI:M
INTRMDTE CONT:ZZ INTRMDTE CONT QTY:ZZZ
PACK CODE:U
MARKING SHALL BE IN ACCORDANCE WITH MIL-STD-129.
SPECIAL MARKING CODE:ZZ -ZZ Special Requirements
PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
SPE2DP-26-T-4809
SECTION B
PR: 7018106186 PRLI: 0001 CONT’D
PACKAGING AND PACKING SHALL BE COMMERCIAL AS
SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED
IN A SUITABLE SEALED UNIT CONTAINER CAPABLE
OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR
BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL
EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN
NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND
SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT
THE LOWEST RATE, TO POINT OF DELIVERY CALLED
FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING
STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES
TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1
(MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA
TROOP SUPPORT VIA EMAIL TO contact@example.gov. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
BULK BREAK POINT:
W50YF2
0051 MD CO MEDICAL LOGISTI
AWCF SSF
BLD A5474 PRATT ST
FORT BRAGG NC 28310
US
SHIP BY FASTEST TRACEABLE MEANS. DO NOT USE PARCEL POST.
FREIGHT SHIPPING ADDRESS:
W50YF2
0051 MD CO MEDICAL LOGISTI
AWCF SSF
BLD A5474 PRATT ST
FORT BRAGG NC 28310
US
MARKFOR
W50YF2
0051 MD CO MEDICAL LOGISTI
AWCF SSF
BLD A5474 PRATT ST
FORT BRAGG NC 28310
US
M/F: (TCN) W50YF262390062
RDD: 239
PROJ: TP 1
SUPP ADD: W9046W SIG: C
FOR GOVERNMENT USE ONLY: (IPD) 02
SPE2DP-26-T-4809
SECTION B
PR: 7018106186 PRLI: 0001 CONT’D
DIC: A0A DIST: V ADV: 2A FC: Z9
Need Ship Date:00/00/0000 Original Required Delivery Date:09/02/2026
SPE2DP-26-T-4809 NSN/Part Number: 6505-01-692-5042 Quantity: 1 BX Purchase Request: 7018111697QTY: 1 Delivery: 5 days ADO